Viron Therapeutics
Latest round
- Series A
Last raised
- May 2006
Total raised
- $20M
Investors
- 6
About Viron Therapeutics
Founded in 1997 and headquartered in London, Canada, Viron Therapeutics specializes in innovative therapeutic solutions. The company has undergone pivotal developments in its strategy since inception, focusing solely on its proprietary porosome platform. The company has completed 1 deal.Viron Therapeutics develops innovative therapies utilizing its proprietary porosome platform designed to address secretory disorders related to diseases such as Alzheimer's, cystic fibrosis, and type 1 diabetes.Viron Therapeutics generates revenue through partnerships and collaborations with healthcare providers, research institutions, and biotechnology companies. Their revenue model involves agreements for research and development, licensing, and commercialization of therapeutic products, emphasizing long-term contracts and clinical partnerships. The company plans to introduce new therapies targeting secretory disorders and expand its reach into North American and European markets by 2025.
Who invested in Viron Therapeutics
6 investors across 1 round
See all investors in Viron Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 16, 2006
Amount
$20M
Investors
Questions about Viron Therapeutics
Who invested in Viron Therapeutics?
Viron Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Viron Therapeutics raised?
Viron Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Viron Therapeutics last raise money?
Viron Therapeutics's most recent round on record is a Series A, in May 2006.
What does Viron Therapeutics do?
Founded in 1997 and headquartered in London, Canada, Viron Therapeutics specializes in innovative therapeutic solutions.
Where is Viron Therapeutics headquartered?
Viron Therapeutics is headquartered in London, Canada.
Which VCs invest in companies like Viron Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Viron Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Viron Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.